Needle in a Haystack? Dealing with 500 000 SNP Genome Scans

Bioinformatics for Geneticists: A Bioinformatics Primer for the Analysis of Genetic Data: Second Edition

Volumn , Issue , 2007, Pages 447-493

  Barnes, Michael R ^a   Derwent, Paul S ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Bioinformatics for genome scan analysis; Gene gene interactions or epistasis; Genome scan analysis issues; Genome scans; Genome wide association scanning

Indexed keywords

EID: 77954260958     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470059180.ch18     Document Type: Chapter

References (73)

1. Altshuler,D.,Hirschhorn, J. N., Klannemark, M. et al. (2000). The common PPARGPro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26, 76-80.
2. Arking, D. E., Pfeufer, A., Post, W. et al. (2006). A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38(6), 644-651.
3. Ashburner, M., Ball, C. A., Blake, J. A. et al. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25(1), 25-29.
4. Balding, D. J., Bishop, M. and Cannings, C. (Eds) (2003). Handbook of Statistical Genetics, 2nd edn. Chichester:Wiley.
5. Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc [Ser B] 57, 289-300.
6. Botstein, D. and Risch, N. (2003). Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33 (Suppl.) 228-237.
7. Camilleri, M., Atanasova, E., Carlson, P. J. et al. (2002). Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 123(2), 425-432.
8. Cardon, L. R. and Palmer, L. J. (2003). Population stratification and spurious allelic association. Lancet 361, 598-604.
9. Churchill, G. A. and Doerge, R. W. (1994). Empirical threshold values for quantitative trait mapping. Genetics 138, 963-971.
10. Clark, A. G., Hubisz, M. J., Bustamante, C. D. et al. (2005). Ascertainment bias in studies of human genome-wide polymorphism. Genome Res 15, 1496-1502.
11. Clarimon, J., Scholz, S., Fung, H.-C. et al. (2006). Conflicting results regarding the semaphorin gene (SEMA5A) and the risk for Parkinson disease. Am J Hum Genet 78, 1082-1084.
12. Cohen, J. C., Pertsemlidis, A., Fahmi, S. et al. (2006). Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci U S A 103(6), 1810-1815.
13. Cordell, H. J. (2002). Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet 11, 2463-2468.
14. de Bakker,P. I.,Yelensky, R.,Pe'er, I. et al. (2005). Efficiency andpower in genetic association studies. Nat Genet 37(11), 1217-1223.
15. Dennis, G., Jr., Sherman, B. T., Hosack, D. A. et al. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4(5), P3.
16. Dudbridge, F. (2006). A note on permutation tests inmultistage association scans.AmJHum Genet 78(6), 1094-1095.
17. Dudbridge, F., Gusnanto, A., Koeleman, B. P. (2006). Detecting multiple associations in genome-wide studies. Hum Genomics 2(5), 310-317.
18. ENCODE Project Consortium (2004). The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306(5696), 636-640.
19. Farrer, M. J., Haugarvoll, K., Ross, O. A. et al. (2006). Genomewide association, Parkinson disease, and PARK10. Am J Hum Genet 78, 1084-1088.
20. Farrer, M. J. (2006). Genetics of Parkinson disease: paradigmshifts and future prospects. Nat Rev Genet 7(4), 306-318.
21. Goris, A., Williams-Gray, C. H., Foltynie, T. et al. (2006). No evidence for association with Parkinson disease for 13 single-nucleotide polymorphisms identified by whole-genome association screening. Am J Hum Genet 78, 1088-1090.
22. Hinds, D. A., Stuve, L. L., Nilsen, G. B. et al. (2005). Whole-genome patterns of common DNA variation in three human populations. Science 307, 1072-1079.
23. Huynh,D.P., Scoles,D. R.,Nguyen,D. et al. (2003). Theautosomal recessive juvenileParkinson disease gene product, parkin, interactswith and ubiquitinates synaptotagmin XI HumMol Genet 12(20), 2587-2597.
24. Ireland, J., Carlton, V. E., Falkowski, M. et al. (2006). Large-scale characterization of public database SNPs causing non-synonymous changes in three ethnic groups Hum Genet 119(1-2), 75-83.
25. Judson, R., Salisbury, B., Schneider, J. et al. (2002). How many SNPs does a genome-wide haplotype map require? Pharmacogenomics 3, 379-391.
26. Kanehisa, M., Goto, S., Kawashima, S. et al. (2004). The KEGG resource for deciphering the genome Nucleic Acids Res 32(Database Issue), D277-280.
27. Ke, X., Hunt, S., Tapper,W. et al. (2004). The impact of SNP density on fine-scale patterns of linkage disequilibrium. Hum Mol Genet 13(6), 577-588.
28. Klein, R. J., Zeiss, C., Chew, E. Y. et al. (2005). Complement factor H polymorphism in age-related macular degeneration. Science 308(5720), 385-389.
29. Kruglyak, L. (1999). Prospects for whole-genome linkage disequilibriummapping of common disease genes. Nat Genet 22, 139-144.
30. Kruglyak, L. (2005). Power tools for human genetics. Nat Genet 37, 1299-1300.
31. Lee, C. C., Lin, S. Z.,Wang, Y. et al. (2003). First human ventral mesencephalon and striatum cografting in a Parkinson patient. Acta Neurochir Suppl 87, 159-162.
32. Li, Y., Rowland, C., Schrodi, S. et al. (2006). A case-control association study of the 12 singlenucleotide polymorphisms implicated in Parkinson disease by a recent genome scan. Am J Hum Genet 78, 1090-1092.
33. Liu, Y., Fallon, L., Lashuel, H. A. et al. (2002). The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111(2), 209-218.
34. Lomax, J. (2005). Get ready to GO! A biologist's guide to the Gene Ontology. Brief Bioinform 6(3), 298-304.
35. Lowe, C. E., Cooper, J. D., Chapman, J. M. et al. (2004). Cost-effective analysis of candidate genes using htSNPs: a staged approach. Genes Immun 5, 301-305.
36. Maraganore, D. M., Lesnick, T. G., Elbaz, A. et al. and UCHL1 Global Genetics Consortium (2004). UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol 55, 512-521.
37. Maraganore, D. M., de Andrade, M., Lesnick, T. G. et al. (2005). High-resolution wholegenome association study of Parkinson disease. Am J Hum Genet 77, 685-693.
38. Maraganore, D. M., de Andrade, M., Lesnick, T. G. et al. (2006). Response from Maraganore et al. Am J Hum Genet 78, 1092-1094.
39. Marchini, J., Donnelly, P. and Cardon, L. R. (2005). Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 37(4), 413-417.
40. Matsuoka, H., Iwata, N., Ito,M.et al. (1997). Expression of a kinase-defectiveEph-like receptor in the normal human brain. Biochem Biophys Res Commun 235(3), 487-492.
41. Matsuzaki, H., Dong, S., Loi, H. et al. (2004). Genotyping over 100,000 SNPs on a pair of oligonucleotide arrays. Nat Methods 1, 109-111.
42. Mitchell, A. A., Cutler, D. J. and Chakravarti, A. (2003). Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test. Am J Hum Genet 72, 598-610.
43. Mootha, V. K., Lepage, P., Miller, K. et al. (2003). Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A 100(2), 605-610.
44. Morris, A. P. (2005). Direct analysis of unphased SNP genotype data in population-based association studies via Bayesian partition modelling of haplotypes. Genet Epidemiol 29(2), 91-107.
45. Newman, T. L., Rieder, M. J., Morrison, V. A. et al. (2006). High-throughput genotyping of intermediate-size structural variation. Hum Mol Genet 15(7), 1159-1167.
46. Nicolae,D. L.,Wen, X.,Voight,B.F. et al. (2006). Coverage and characteristics of theAffymetrix GeneChip Human Mapping 100K SNP Set PLoS Genet 2(5), e67.
47. Pe'er, I., Chretien, Y. R., de Bakker, P. I. et al. (2006a). Biases and reconciliation in estimates of linkage disequilibrium in the human genome. Am J Hum Genet 78, 588-603.
48. Pe'er, I., de Bakker, P. I., Maller, J. et al. (2006b). Evaluating and improving power in wholegenome association studies using fixed marker sets. Nat Genet 38(6), 663-667.
49. Pisani, A., Centonze, D., Bernardi, G. et al. (2005). Striatal synaptic plasticity: implications for motor learning and Parkinson's disease. Mov Disord 20(4), 395-402.
50. Pritchard, J. K. (2001). Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69, 124-137.
51. Pritchard, J. K. and Przeworski, M. (2001). Linkage disequilibrium in humans: models and data. Am J Hum Genet 69(1), 1-14.
52. Purcell, S., Cherny, S. S. and Sham, P. C. (2003). Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1), 149-150.
53. Quackenbush, J. (2001). Computational analysis of microarray data. Nat Rev Genet 2(6), 418-427.
54. Reich, D. E. and Lander, E. S. (2001). On the allelic spectrum of human disease. Trends Genet 17, 502-510.
55. Risch, N. and Merikangas, K. (1996). The future of genetic studies of complex human diseases. Science 273, 1516-1517.
56. Royce, T. E., Rozowsky, J. S., Bertone, P. et al. (2005). Issues in the analysis of oligonucleotide tiling microarrays for transcript mapping. Trends Genet 21(8), 466-475.
57. Schaid,D. J. and Rowland, C. (1998). Use of parents, sibs, and unrelated controls for detection of associations between genetic markers and disease. Am J Hum Genet 63, 1492-1506.
58. Service, R. F. (2006). Gene sequencing. The race for the $1000 genome. Science 311(5767), 1544-1546.
59. Skipper, L., Li, Y., Bonnard, C. et al. (2005). Comprehensive evaluation of common genetic variationwithin LRRK2 reveals evidence for associationwith sporadic Parkinson's disease. Hum Mol Genet 14(23), 3549-3556.
60. Slater, H. R., Bailey,D. K.,Ren, H. et al. (2005). High-resolution identification of chromosomal abnormalities using oligonucleotide arrays containing 116,204 SNPs Am J Hum Genet 77(5), 709-726.
61. SNP Consortium (2001). A map of human genome sequence variation containing 1.4 million SNPs. Nature 409, 928-933.
62. Spector, T.D., Ahmadi, K. R. andValdes, A. M. (2006). When is a replication not a replication? Or how to spot a good genetic association study Arthritis Rheum 54(4), 1051-1054.
63. Steemers, F. J., Chang,W., Lee, G. et al. (2006). Whole-genome genotypingwith the single-base extension assay Nat Methods 3(1), 31-33.
64. Tan, E. K., Puong, K. Y., Chan, D. K. et al. (2005). Impaired transcriptional upregulation of parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association Hum Genet 118(3-4), 484-488.
65. Terwilliger, J. D. and Hiekkalinna, T. (2006). An utter refutation of the 'fundamental theorem of the HapMap'. Eur J HumGenet 14, 426-437.
66. Thomas, D. C., Haile, R. W. and Duggan, D. (2005). Recent developments in genomewide association scans: a workshop summary and review. Am J Hum Genet 77, 337-345.
67. Verducci, J. S., Melfi, V. F., Lin, S. et al. (2006). Microarray analysis of gene expression: considerations in data mining and statistical treatment. Physiol Genomics 25(3), 355-363.
68. Vermeire, S.,Wild, G., Kocher, K. et al. (2002). CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet 71(1), 74-83.
69. Wang, W. Y., Barratt, B. J., Clayton, D. G. et al. (2005). Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 6(2), 109-118.
70. Wang, H., Thomas, D. C., Pe'er, I. et al. (2006). Optimal two-stage genotyping designs for genome-wide association scans. Genet Epidemiol 30(4), 356-368.
71. Weiss, K. M. and Terwilliger, J. D. (2000). How many diseases does it take to map a gene with SNPs? Nat Genet 26, 151-157.
72. West, A. B.,Maraganore, D., Crook, J. et al. (2002). Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet 11(22), 2787-2792.
73. Wright, A. F. and Hastie, N.D. (2001). Complex genetic diseases: controversy over theCroesus code. Genome Biol 2, 2007.